logo
Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis
The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-α-stimulated host cells
Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication
Detailed analysis of the E2–IgM complex in hepatitis C-related type II mixed cryoglobulinaemia
Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus
A prospective assessment of an ‘a la carte’ regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers
Hepatitis C virus free-virion and immune-complex dynamics during interferon therapy with and without ribavirin in genotype-1b chronic hepatitis C patients
Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C
The current pattern of hepatitis B virus infection in Australia